Poliomyelitis
📧 Sign up to get email alerts when something new happens for Poliomyelitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV [Phase 4]
A Phase 4 clinical trial update assessing the immunogenicity of novel oral poliovirus vaccine type 2 (nOPV2), bOPV, and IPV.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of an inactivated adjuvanted polio vaccine compared with licensed inactivated poliovirus …
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV [Phase 3]
A Phase 3 clinical trial evaluating safety and immunogenicity of different sequential schedules of bOPV and IPV for poliomyelitis has comple…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV) [Phase 3]
A Phase 3 clinical trial protocol update for the Sabin-strain inactivated poliovirus vaccine (Sabin IPV) completed.
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Consistency Study for Three Commercial Lots of Inactivated Poliomyelitis Vaccine Made From Sabin Strain [Phase 4]
A Phase 4 consistency study evaluating three commercial lots of inactivated poliomyelitis vaccine made from Sabin strain has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Inactivated Poliomyelitis Vaccine Made From Sabin Strain [Phase 4]
Phase 4 trial updating an inactivated polio vaccine made from Sabin strain; completed the study.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell) [Phase 2, Phase 3]
Clinical trial update for the immunogenicity and safety of a live attenuated poliomyelitis vaccine (Human Diploid Cell) addressing poliomyel…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016) [Phase 4]
Phase 4 study assessing safety, tolerability, and immunogenicity of the hexavalent vaccine Vaxelis in children previously vaccinated with Va…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS [Phase 3]
Phase 3 trial update for a diphtheria-tetanus-acellular pertussis-inactivated poliovirus combination vaccine were completed.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the immunogenicity and safety of LBVD(Hexavalent Vaccine) in healthy infants as part of the primary seri…
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants [Phase 4]
Phase 4 safety study of Sabin Inactivated Poliovirus Vaccine in infants completed.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Clinical Trial of Novel OPV2 Vaccine [Phase 2]
Phase 2 clinical trial update for a novel OPV2 vaccine addressing poliomyelitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Immunogenicity of Intramuscular and Intradermal IPV [Phase 4]
A Phase 4 trial evaluating immunogenicity of intramuscular and intradermal inactivated polio vaccine (IPV) has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants [Phase 3]
Phase 3 trial comparing primary and booster DTaP-IPV-Hib vaccinations to co-administration of DTaP-IPV and Hib in Japanese infants; study co…
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh [Phase 4]
Phase 4 trial assessing immunogenicity of one- and two-dose poliovirus type 2 schedule using IPV and fIPV in children aged 9-13 months in Ba…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth [Phase 3]
Phase 3 trial update evaluating the immunogenicity and safety of Sanofi Pasteur's combined vaccine given as a three-dose primary series in i…
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine [Phase 2]
Phase 2 trial assessing safety and immunogenicity of a novel oral polio vaccine has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-07Clinical Trial Update: Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China [Phase 4]
Phase 4 clinical trial update assessing immunogenicity and safety of polio booster dose across different primary sequential schedules in Chi…
-
CLINICAL_TRIALS withdrawal · 2022-01-14Clinical Trial Update: Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine [Phase 3]
Phase 3 clinical trial evaluating concomitant administration of Novel Oral Polio Type 2 vaccine with a bivalent OPV has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates [Phase 2]
Phase 2 study evaluating safety and immunogenicity of two oral poliovirus vaccine candidates completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine [Phase 3]
Phase 3 lot-consistency trial of Sabin strain inactivated polio vaccine (IPV) completed.
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®) [Phase 4]
Phase 4 trial evaluating persistence of immunity in 4-year-olds previously immunised with IPV-Al AJV (Picovax®) for poliomyelitis.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study [Phase 4]
A Phase 4 clinical trial update evaluating monovalent oral poliovirus vaccine type 1 for intestinal and humoral immunity has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults [Phase 1]
Phase 1 study of a novel live attenuated serotype 2 oral polio vaccine in adults primed with IPV showed completed status with posted results…
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Duration of IPV Priming and Antibody Decay [Phase 4]
A Phase 4 clinical trial update examining IPV priming duration and antibody decay for poliomyelitis has completed.